W. B. Isaacs

Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression.

R. Vessella, W. Isaacs, C. Sawyers, 1998, Proceedings of the National Academy of Sciences of the United States of America.

Large-scale association analysis in Asians identifies new susceptibility loci for prostate cancer

Chao Qin, Fang Liu, Qiang Ding, 2015, Nature Communications.

Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21

Gary K. Chen, M. C. Leske, J. Witte, 2011, Nature Genetics.

A genome-wide survey over the ChIP-on-chip identified androgen receptor binding genomic regions identifies a novel prostate cancer susceptibility locus at 12q13.13

Jielin Sun, Seong‐Tae Kim, H. Gronberg, 2011 .

Androgen Receptor Signaling in Prostate Cancer: New Twists for an Old

Wennuan Liu, S. Zheng, S. Lilly Zheng, 2011 .

Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer

Kevin M. Bradley, D. Gudbjartsson, A. Sigurdsson, 2008, Nature Genetics.

Characterizing Genetic Risk at Known Prostate Cancer Susceptibility Loci in African Americans

Gary K. Chen, J. Witte, M. Thun, 2011, PLoS genetics.

Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21

Gary K. Chen, J. Witte, M. Thun, 2011, Nature Genetics.

Germline mutations in the ribonuclease L gene in families showing linkage with HPC1

K. Klinger, P. Meltzer, J. Carpten, 2002, Nature Genetics.

Germline mutations in HOXB13 and prostate-cancer risk.

J. Carpten, K. Cooney, A. Ray, 2012, The New England journal of medicine.

P-Cadherin is a basal cell-specific epithelial marker that is not expressed in prostate cancer.

W. Isaacs, J. Schalken, A. van Bokhoven, 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.